Guardant Health Inc
NASDAQ:GH
Balance Sheet
Balance Sheet Decomposition
Guardant Health Inc
Guardant Health Inc
Balance Sheet
Guardant Health Inc
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
34
|
72
|
141
|
143
|
833
|
492
|
142
|
1 134
|
526
|
|
| Cash Equivalents |
34
|
72
|
141
|
143
|
833
|
492
|
142
|
1 134
|
526
|
|
| Short-Term Investments |
62
|
149
|
278
|
380
|
962
|
441
|
870
|
35
|
314
|
|
| Total Receivables |
4
|
13
|
36
|
48
|
53
|
98
|
97
|
89
|
110
|
|
| Accounts Receivables |
4
|
13
|
36
|
48
|
53
|
98
|
97
|
89
|
110
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
3
|
7
|
9
|
15
|
23
|
31
|
52
|
62
|
71
|
|
| Other Current Assets |
2
|
2
|
5
|
11
|
18
|
53
|
32
|
28
|
34
|
|
| Total Current Assets |
103
|
243
|
469
|
597
|
1 888
|
1 114
|
1 192
|
1 347
|
1 055
|
|
| PP&E Net |
13
|
16
|
31
|
73
|
100
|
314
|
342
|
303
|
279
|
|
| PP&E Gross |
13
|
16
|
31
|
73
|
100
|
314
|
342
|
303
|
279
|
|
| Accumulated Depreciation |
7
|
11
|
17
|
22
|
34
|
55
|
88
|
127
|
166
|
|
| Intangible Assets |
0
|
0
|
0
|
9
|
16
|
14
|
12
|
9
|
7
|
|
| Goodwill |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Long-Term Investments |
0
|
73
|
78
|
269
|
247
|
698
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
11
|
10
|
12
|
17
|
61
|
62
|
124
|
141
|
|
| Other Assets |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Total Assets |
117
N/A
|
343
+194%
|
587
+71%
|
963
+64%
|
2 272
+136%
|
2 205
-3%
|
1 610
-27%
|
1 786
+11%
|
1 486
-17%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
3
|
5
|
11
|
16
|
7
|
18
|
69
|
52
|
39
|
|
| Accrued Liabilities |
4
|
10
|
19
|
41
|
46
|
84
|
107
|
136
|
152
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
7
|
4
|
18
|
15
|
13
|
94
|
17
|
18
|
35
|
|
| Total Current Liabilities |
14
|
20
|
47
|
73
|
67
|
195
|
193
|
206
|
226
|
|
| Long-Term Debt |
17
|
1
|
0
|
0
|
806
|
1 135
|
1 137
|
1 140
|
1 143
|
|
| Minority Interest |
0
|
0
|
42
|
50
|
57
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
6
|
14
|
15
|
42
|
43
|
230
|
219
|
282
|
257
|
|
| Total Liabilities |
37
N/A
|
34
-7%
|
104
+204%
|
164
+57%
|
973
+493%
|
1 560
+60%
|
1 550
-1%
|
1 628
+5%
|
1 625
0%
|
|
| Equity | ||||||||||
| Common Stock |
180
|
500
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
108
|
196
|
281
|
353
|
607
|
1 008
|
1 662
|
2 142
|
2 578
|
|
| Additional Paid In Capital |
7
|
5
|
764
|
1 150
|
1 902
|
1 658
|
1 742
|
2 304
|
2 444
|
|
| Unrealized Security Profit/Loss |
0
|
1
|
0
|
1
|
3
|
5
|
20
|
4
|
5
|
|
| Total Equity |
80
N/A
|
309
+287%
|
483
+57%
|
798
+65%
|
1 299
+63%
|
645
-50%
|
60
-91%
|
159
+164%
|
140
N/A
|
|
| Total Liabilities & Equity |
117
N/A
|
343
+194%
|
587
+71%
|
963
+64%
|
2 272
+136%
|
2 205
-3%
|
1 610
-27%
|
1 786
+11%
|
1 486
-17%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
84
|
84
|
86
|
94
|
100
|
100
|
103
|
122
|
124
|
|